| Challenges in antibody development against Tn and Sialyl-Tn antigens LR Loureiro, MA Carrascal, A Barbas, JS Ramalho, C Novo, P Delannoy, ... Biomolecules 5 (3), 1783-1809, 2015 | 104 | 2015 |
| “UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells N Mitwasi, A Feldmann, C Arndt, S Koristka, N Berndt, J Jureczek, ... Scientific reports 10 (1), 2141, 2020 | 76 | 2020 |
| Adaptor car platforms—Next generation of T cell-based cancer immunotherapy C Arndt, F Fasslrinner, LR Loureiro, S Koristka, A Feldmann, M Bachmann Cancers 12 (5), 1302, 2020 | 50 | 2020 |
| Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells LR Loureiro, A Feldmann, R Bergmann, S Koristka, N Berndt, C Arndt, ... Blood cancer journal 8 (9), 81, 2018 | 46 | 2018 |
| Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy A Feldmann, A Hoffmann, R Bergmann, S Koristka, N Berndt, C Arndt, ... Oncoimmunology 9 (1), 1785608, 2020 | 45 | 2020 |
| Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids LR Loureiro, DP Sousa, D Ferreira, W Chai, L Lima, C Pereira, CB Lopes, ... Scientific reports 8 (1), 12196, 2018 | 43 | 2018 |
| Comparison of the stability of Y-90-, Lu-177-and Ga-68-labeled human serum albumin microspheres (DOTA-HSAM) G Wunderlich, E Schiller, R Bergmann, HJ Pietzsch Nuclear medicine and biology 37 (8), 861-867, 2010 | 42 | 2010 |
| Preliminary investigations on the determination of three‐dimensional dose distributions using scintillator blocks and optical tomography F Kroll, J Pawelke, L Karsch Medical Physics 40 (8), 082104, 2013 | 41* | 2013 |
| UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells C Arndt, LR Loureiro, A Feldmann, J Jureczek, R Bergmann, D Máthé, ... Oncoimmunology 9 (1), 1743036, 2020 | 32 | 2020 |
| Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers LR Loureiro, A Feldmann, R Bergmann, S Koristka, N Berndt, D Máthé, ... Journal of Experimental & Clinical Cancer Research 39, 1-13, 2020 | 28 | 2020 |
| Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab® J Jureczek, A Feldmann, R Bergmann, C Arndt, N Berndt, S Koristka, ... OncoTargets and therapy, 5515-5527, 2020 | 18 | 2020 |
| Targeting acute myeloid leukemia using the RevCAR platform: a programmable, switchable and combinatorial strategy E Kittel-Boselli, KEG Soto, LR Loureiro, A Hoffmann, R Bergmann, ... Cancers 13 (19), 4785, 2021 | 17 | 2021 |
| oxSWATH: An integrative method for a comprehensive redox-centered analysis combined with a generic differential proteomics screening SI Anjo, MN Melo, LR Loureiro, L Sabala, P Castanheira, M Grãos, ... Redox biology 22, 101130, 2019 | 16 | 2019 |
| Design and biological evaluation of small-molecule PET-tracers for imaging of programmed death ligand 1 F Krutzek, CK Donat, M Ullrich, K Zarschler, MC Ludik, A Feldmann, ... Cancers 15 (9), 2638, 2023 | 13 | 2023 |
| Development and functional characterization of a versatile radio-/immunotheranostic tool for prostate cancer management C Arndt, R Bergmann, F Striese, K Merkel, D Máthé, LR Loureiro, ... Cancers 14 (8), 1996, 2022 | 11 | 2022 |
| Tonic signaling and its effects on lymphopoiesis of CAR-armed hematopoietic stem and progenitor cells S Albert, S Koristka, A Gerbaulet, M Cartellieri, C Arndt, A Feldmann, ... The Journal of Immunology 202 (6), 1735-1746, 2019 | 10 | 2019 |
| And yet it moves: oxidation of the nuclear autoantigen la/SS-B is the driving force for nucleo-cytoplasmic shuttling N Berndt, CC Bippes, I Michalk, T Bartsch, C Arndt, E Puentes-Cala, ... International Journal of Molecular Sciences 22 (18), 9699, 2021 | 9 | 2021 |
| T cell mediated conversion of a non-anti-La reactive B cell to an autoreactive anti-La B cell by somatic hypermutation MP Bachmann, T Bartsch, CC Bippes, D Bachmann, E Puentes-Cala, ... International journal of molecular sciences 22 (3), 1198, 2021 | 9 | 2021 |
| A novel revcar platform for switchable and gated tumor targeting A Feldmann, A Hoffmann, E Kittel-Boselli, R Bergmann, S Koristka, ... Blood 134, 5611, 2019 | 8 | 2019 |
| Application of Hyperthermia for Cancer Treatment: Synthesis and Characterization of Magnetic Nanoparticles and their internalization on Tumor Cell Lines* CIP Chaparro, LR Loureiro, MA Valente, PA Videira, JP Borges, ... 2019 IEEE 6th Portuguese Meeting on Bioengineering (ENBENG), 1-4, 2019 | 8 | 2019 |
